The lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes growth and progression in prostate cancer (PCa); however, little is known about its possible impact in PCa metabolism. The aim of this work has been the assessment of the metabolic reprogramming associated with MALAT1 silencing in human PCa cells and in an ex vivo model of organotypic slice cultures (OSCs). Cultured cells and OSCs derived from primary tumors were transfected with MALAT1 specific gapmers. Cell growth and survival, gene profiling, and evaluation of targeted metabolites and metabolic enzymes were assessed. Computational analysis was made considering expression changes occurring in metabolic markers following MALAT1 targeting in cultured OSCs. MALAT1 silencing reduced expression of some metabolic enzymes, including malic enzyme 3, pyruvate dehydrogenase kinases 1 and 3, and choline kinase A. Consequently, PCa metabolism switched toward a glycolytic phenotype characterized by increased lactate production paralleled by growth arrest and cell death. Conversely, the function of mitochondrial succinate dehydrogenase and the expression of oxidative phosphorylation enzymes were markedly reduced. A similar effect was observed in OSCs. Based on this, a predictive algorithm was developed aimed to predict tumor recurrence in a subset of patients. MALAT1 targeting by gapmer delivery restored normal metabolic energy pathway in PCa cells and OSCs.

Nanni, S., Aiello, A., Salis, C., Re, A., Cencioni, C., Bacci, L., Pierconti, F., Pinto, F., Ripoli, C., Ostano, P., Baroni, S., Lazzarino, G., Tavazzi, B., Pugliese, D., Bassi, P., Grassi, C., Panunzi, S., Chiorino, G., Pontecorvi, A., Gaetano, C., Farsetti, A., Metabolic reprogramming by malat1 depletion in prostate cancer, <<CANCERS>>, 2020; 13 (1): 1-29. [doi:10.3390/cancers13010015] [http://hdl.handle.net/10807/177483]

Metabolic reprogramming by malat1 depletion in prostate cancer

Nanni S.
;
Salis C.;Re A.;Bacci L.;Pierconti F.;Pinto F.;Ripoli C.;Baroni S.;Lazzarino G.;Tavazzi B.;Bassi P.;Grassi C.;Panunzi S.;Pontecorvi A.;
2021

Abstract

The lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes growth and progression in prostate cancer (PCa); however, little is known about its possible impact in PCa metabolism. The aim of this work has been the assessment of the metabolic reprogramming associated with MALAT1 silencing in human PCa cells and in an ex vivo model of organotypic slice cultures (OSCs). Cultured cells and OSCs derived from primary tumors were transfected with MALAT1 specific gapmers. Cell growth and survival, gene profiling, and evaluation of targeted metabolites and metabolic enzymes were assessed. Computational analysis was made considering expression changes occurring in metabolic markers following MALAT1 targeting in cultured OSCs. MALAT1 silencing reduced expression of some metabolic enzymes, including malic enzyme 3, pyruvate dehydrogenase kinases 1 and 3, and choline kinase A. Consequently, PCa metabolism switched toward a glycolytic phenotype characterized by increased lactate production paralleled by growth arrest and cell death. Conversely, the function of mitochondrial succinate dehydrogenase and the expression of oxidative phosphorylation enzymes were markedly reduced. A similar effect was observed in OSCs. Based on this, a predictive algorithm was developed aimed to predict tumor recurrence in a subset of patients. MALAT1 targeting by gapmer delivery restored normal metabolic energy pathway in PCa cells and OSCs.
Inglese
Nanni, S., Aiello, A., Salis, C., Re, A., Cencioni, C., Bacci, L., Pierconti, F., Pinto, F., Ripoli, C., Ostano, P., Baroni, S., Lazzarino, G., Tavazzi, B., Pugliese, D., Bassi, P., Grassi, C., Panunzi, S., Chiorino, G., Pontecorvi, A., Gaetano, C., Farsetti, A., Metabolic reprogramming by malat1 depletion in prostate cancer, <>, 2020; 13 (1): 1-29. [doi:10.3390/cancers13010015] [http://hdl.handle.net/10807/177483]
File in questo prodotto:
File Dimensione Formato  
Cancers 13,15, 2021.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 4.38 MB
Formato Adobe PDF
4.38 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/177483
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact